Innovative Clinical Trials through Jumo Health’s PRISM™
PRISM™ is a groundbreaking system that redefines how clinical trials approach patient readiness, marking a significant evolution in the way these studies are executed. By prioritizing patient preparedness as essential to the completion rate of trials, Jumo Health aims to overcome common obstacles that lead to failure in clinical research.
The Challenge of Patient Participation
Clinical trials often encounter obstacles that stem not from the inability to find patients, but from the complexities associated with ongoing participation. Many individuals may be eligible for a study, but that does not mean they are adequately prepared for the demands of participation. Jumo Health recognizes this persistent challenge and is addressing it with the launch of PRISM™. This system emphasizes readiness as a central factor in patient involvement.
CEO Brittany Erana explains, "Clinical trials have focused heavily on recruitment strategies without considering if patients are truly prepared to engage. PRISM flips the narrative, establishing readiness as an essential requirement rather than an overlooked aspect of trial execution." By reshaping the model of trial execution, PRISM offers a method that promotes inclusivity and significantly enhances the likelihood of successful completion.
Understanding Unreadiness Factors
Traditional approaches to managing clinical trials emphasize recruitment metrics, such as the number of patients enrolled. However, this does not address whether participants are mentally and emotionally prepared for their commitments. PRISM confronts this issue by changing the way readiness is assessed and ensured before and during a trial.
How PRISM™ Works
PRISM™ integrates various strategies to operationalize patient readiness meticulously. Unlike conventional models that measure eligibility first, PRISM is designed to evaluate emotional and cognitive readiness from the onset, thus preventing dropout rates that often occur midway through trials. This paradigm shift allows for better management of patient engagement and retention, ensuring that participants are not only signed up but actively engaged.
Essential Features of PRISM™
The core features of PRISM™ include:
- Readiness Assessment: A systematic approach to determine who is ready to engage in a trial.
- Decision Science Applications: Employing cognitive strategies to alleviate the burden on participants, helping them make informed decisions.
- Optimized Pre-Screening: Ensuring that only suitable candidates progress to trial sites, thereby saving time and resources.
- Lifecycle Governance: Monitoring readiness constantly throughout the trial duration to anticipate and address potential dropouts.
- Retention Strategies: Implementing early interventions to assist participants, preventing them from exiting the study prematurely.
The Impact of Readiness on Clinical Trials
Jumo Health envisions that by employing the PRISM™ framework, it can drastically reduce the disruptions that often plague clinical trials. By governing patient readiness actively, the system ensures that participation is not only feasible but sustainable. This operational approach is particularly vital in scenarios where trials involve significant emotional and logistical challenges.
Jumo Health stands as a leader in patient experience, having established a reputation for facilitating better participant engagement through education and support. With PRISM™, they are expanding their impact and enhancing the trust patients place in clinical studies, ultimately leading to a higher completion rate of trials.
About Jumo Health
With backing from Falfurrias Capital Partners, Jumo Health is at the forefront of redefining patient interaction in clinical research. They tackle essential questions surrounding patient preparedness and engagement, paving the way for innovations that benefit both participants and pharmaceutical sponsors.
Through the integration of artificial intelligence and real-world data, Jumo Health creates tailored solutions that mitigate the barriers faced by patients in clinical trials. Their extensive partnerships span across numerous therapeutic areas, working with leading life sciences organizations to broaden access and improve trial outcomes.
Frequently Asked Questions
What is PRISM™ by Jumo Health?
PRISM™ is a readiness-based clinical trial management system designed to enhance patient engagement and completion rates by focusing on patient preparedness.
How does PRISM™ improve clinical trial execution?
By prioritizing readiness over mere eligibility, PRISM™ ensures patients are fully prepared for the demands of clinical trial participation, reducing dropout rates and increasing predictability.
Why is patient readiness important in clinical trials?
Patient readiness is crucial as it directly impacts participation and retention rates. Understanding and addressing it can lead to more successful trials.
What types of solutions does Jumo Health provide?
Jumo Health integrates AI, real-world data, and behavioral science to create systems that facilitate better patient engagement throughout the clinical trial lifecycle.
Who can benefit from the PRISM™ system?
Biopharma sponsors and research partners, particularly in complex therapeutic areas, can utilize PRISM™ to optimize their clinical trials and improve patient outcomes.
